Boston Children's Hospital (BCH)
7 articles with Boston Children's Hospital (BCH)
-
Boston Children’s Hospital and Deerfield Join Forces to Accelerate the Development of Novel Therapies to Patients
11/10/2020
Boston Children’s Hospital, which has the largest National Institutes of Health-funded pediatric research enterprise in the United States, and Deerfield Management Company, a healthcare investment firm, announced a major research collaboration to advance promising therapeutics that will address unsolved medical needs and find cures for disease.
-
Game Day on November 7th to Support Boston Children's Hospital
11/5/2020
Online gaming event will bring awareness to nation's top pediatric hospital; will raise funds for critical research to help heal the sickest children
-
Boston Children's Hospital to Host Online Rocket League Gaming Tournament
7/7/2020
Boston Children's Hospital is working with Boston Rocket League and Extra Life to host a Rocket League gaming tournament on July 11 and 12.
-
Boston Children's Hospital ranked #1 in the nation by U.S. News & World Report for seventh year in a row
6/16/2020
Boston Children's Hospital is the number one pediatric hospital in the nation for the seventh year in a row according to U.S. News & World Report's 2020-21 Best Children's Hospitals Honor Roll.
-
Boston Children's Hospital's Center on Media and Child Health releases an essential guide for parents concerned about kids' screen use
5/21/2020
Boston Children's Hospital's Center on Media and Child Health (CMCH) today released the " Family Digital Wellness Guide ," a free interactive handbook of essential evidence-based "Protips" for p
-
Boston Children's Hospital researchers used an investigational gene therapy to treat heart failure in a mouse model of Barth syndrome.
-
IDEAYA Biosciences and Boston Children's Hospital Collaborate on Preclinical Evaluation of IDE196 for Sturge Weber Syndrome - a Rare Disease Associated with Genetic Mutation of GNAQ
1/10/2020
IDEAYA Biosciences, Inc. announced that the company has entered into a Sponsored Research Agreement with Boston Children's Hospital for preclinical evaluation of the role of protein kinase C in Sturge Weber syndrome, a rare neurocutaneous disorder characterized by capillary malformations and associated with mutations in GNAQ.